Literature DB >> 20485404

Neglected diseases fund touted.

Declan Butler.   

Abstract

Mesh：

Substances：

Year:  2010        PMID： 20485404     DOI： 10.1038/465277a

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  3 in total

Review 1.  Non-profit Drug Research and Development at a Crossroads.

Authors:  Szymon Jarosławski; Mondher Toumi; Pascal Auquier; Claude Dussart
Journal:  Pharm Res       Date:  2018-02-07       Impact factor: 4.200

2.  Phosphodiesterase inhibitors as a new generation of antiprotozoan drugs: exploiting the benefit of enzymes that are highly conserved between host and parasite.

Authors:  Thomas Seebeck; Geert Jan Sterk; Hengming Ke
Journal:  Future Med Chem       Date:  2011-08       Impact factor: 3.808

3.  Non-profit drug research and development: the case study of Genethon.

Authors:  Szymon Jarosławski; Mondher Toumi
Journal:  J Mark Access Health Policy       Date:  2018-11-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.